Athenex, Inc. ( ATNX) - Stock Earnings
Stock symbol ATNX is outdated, potentially delisted? Maybe it is available on other exchange?
ATNX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -32.2 million USD | 31.5 million USD |
| 2022Q3 | -19.7 million USD | 33.5 million USD |
| 2022Q4 | -34.2 million USD | 8.6 million USD |
ATNX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -146.2 million USD | 144.4 million USD |
| 2021 | -199.8 million USD | 120.2 million USD |
| 2022 | -103.4 million USD | 102.8 million USD |
ATNX
Price: $0.20
52 week price:
Earnings Per Share: -1.52 USD
P/E Ratio: -1.42
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 12.1 million
Ebitda: -22.0 millionMarket Capitalization: 2.3 million